Viscofresh

Quick links to important sections

Viscofresh

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Viscofresh

What is Viscofresh?

Viscofresh is an ophthalmic solution used to provide relief from symptoms associated with eye dryness. It is classified as an artificial tear or ocular lubricant. The solution is formulated to mimic the properties of natural tears, helping to maintain moisture on the surface of the eye.

Composition and Mechanism

The primary active ingredient in Viscofresh is carmellose sodium (also known as carboxymethylcellulose sodium). This substance is a polymer that exhibits mucoadhesive properties, allowing it to adhere to the ocular surface.

When applied to the eye, Viscofresh works by:

  • Supplementing the Tear Film: It adds volume to the natural tear layer, which may be deficient in individuals with dry eye conditions.
  • Increasing Viscosity: The formulation has a higher viscosity than water, which helps the solution remain on the eye surface for a longer duration, providing prolonged lubrication.
  • Stabilizing the Tear Film: It helps to reduce the evaporation of natural tears by forming a protective shield over the cornea and conjunctiva.

Physical Characteristics

Viscofresh is typically presented as a clear, colorless, and sterile aqueous solution. It is often available in single-dose containers, which are designed for one-time use. These single-dose units are frequently preservative-free, making them suitable for individuals who have sensitivities to preservatives or those who require frequent application throughout the day.

Intended Use

This solution is used to manage ocular discomfort caused by environmental factors or physiological conditions that lead to a decrease in tear production or an increase in tear evaporation. Common situations where this lubricant may be used include:

  • Exposure to wind, sun, or dry air (such as air conditioning or heating).
  • Prolonged use of computer screens or digital devices, which can decrease the blink rate.
  • General sensations of dryness, burning, or a foreign body sensation ('grittiness') in the eyes.

Regulatory References

  1. Carboxymethylcellulose Ophthalmic (Lubricant) Information

What side effects are possible with Viscofresh?

Possible Side Effects and Safety Information

The safety profile of Viscofresh, an ophthalmic preparation containing carmellose sodium, is primarily characterized by reactions localized to the eye, reflecting its negligible systemic absorption, as documented in official regulatory sources.


Adverse Reaction Classification

Adverse reactions are grouped according to their frequency, with the majority falling under Eye Disorders System-Organ Class (SOC).

Frequency Classification Examples of Listed Effects
Common (ge 1/100 to < 1/10) Eye irritation (including burning and discomfort), eye pain, visual disturbance, eye pruritus (itching).
Uncommon (ge 1/1,000 to < 1/100) Blurred vision, increased lacrimation (tearing), ocular hyperemia (eye redness), eye discharge, hypersensitivity (allergic reaction).

Safety Constraints and Special Populations

Time-Related Effects are noted in official labeling; for instance, transient blurring of vision may occur immediately after application. Common local effects such as burning are typically mild and last for only a few minutes.

Serious Adverse Reactions are documented as Very Rare safety events and are typically related to severe systemic allergic reactions (e.g., anaphylaxis). Use of the product is Contraindicated in individuals with known hypersensitivity to carmellose sodium or any of its excipients.

For Special Populations, the medicine is considered acceptable for use during pregnancy and lactation due to the lack of pharmacological activity and negligible systemic exposure. Safety and efficacy in the paediatric population are based on clinical experience, with adult usage patterns applied.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Viscofresh (Carmellose sodium ophthalmic solution) is defined by its negligible systemic absorption when administered topically. Regulatory labeling explicitly states that accidental topical overdose—meaning over-instillation of the drops into the eye—will present no hazard. The active ingredient is a high molecular weight polymer and is not expected to penetrate the eye's surface, preventing systemic toxicity from ocular use.


Emergency Response and Required Actions

The primary concern detailed in regulatory guidance is accidental oral ingestion of the solution. This circumstance requires immediate action. The official prescribing information mandates that if the product is swallowed, the individual must immediately contact a Poison Control Center or seek urgent medical help. This required action is particularly emphasized regarding pediatric populations.

Monitoring and supportive measures are context-dependent. Symptomatic and supportive treatment is the documented approach for managing accidental oral ingestion. No specific antidote is listed in the official labeling for this product.


Summary of Official Overdose Profile

The regulatory documents define the overdose profile by the classification of accidental ocular over-administration as non-hazardous, meaning severe outcomes are not expected from topical use. The guidance on seeking urgent medical help is triggered strictly by accidental oral ingestion, reflecting the documented risk constraints.

Therapeutic Uses of Viscofresh

What Viscofresh treats: main uses and benefits

The active ingredient in Viscofresh (carmellose sodium) is a lubricant used in artificial tears to treat dry eyes. It is intended to help with the treatment of the symptoms of dry eye.

One of the main patient benefits is providing supportive, soothing lubrication that may assist with maintaining functional stability when these uncomfortable symptoms become more noticeable. This medication is used in situations involving certain distressing symptoms associated with mild to moderate dry eyes and is applied where additional symptomatic support is needed. It helps address symptom clusters that commonly appear together, such as dryness, a feeling of grittiness or scratchiness, and an accompanying stinging or burning sensation.

It is commonly used in situations involving recurrent or episodic manifestations, particularly irritation caused by environmental factors (like wind or dry air) or functional strain from extended tasks like screen use, and may be part of symptomatic management for chronic Dry Eye Syndrome. This contributes to easing the overall symptom load, which may help patients cope more steadily with symptom fluctuations.

“It provides symptomatic relief that helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.”

Quick Fact: Relevant for Easing Symptoms of Dryness and Irritation

Eligibility and Restrictions for Use

Who Must Not Use Viscofresh?

The only absolute contraindication stated in regulatory labeling is known hypersensitivity (allergy) to the active substance, carmellose sodium, or to any of the excipients used in the formulation. Patients with a documented allergy to any component must not use this medicine.


Eligibility for General and Special Populations

Adults and older adults are eligible for standard use. Use is generally permitted for pregnant and breast-feeding women because official regulatory documentation confirms the product has negligible systemic exposure.

Specific eligibility limitations related to renal or hepatic impairment are not documented in regulatory labeling.

Children and Adolescents: Use in the pediatric population is often allowed based on clinical experience. However, official labeling notes that formal safety and efficacy have not been established by clinical trial data.


Conditional Exclusion

Use of the product must be discontinued if new or worsening ocular symptoms occur. These conditional exclusion criteria include persistent pain, redness, changes in vision, or increased irritation, requiring the user to seek a clinical assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Viscofresh (Carmellose sodium ophthalmic solution) is highly specific, reflecting its local action on the ocular surface and minimal absorption into the body. This structure is consistent across official regulatory documentation.


Systemic and Metabolic Profile

Due to the product's high molecular weight and negligible systemic exposure, no known metabolic (e.g., CYP enzyme) or systemic drug-drug interactions are documented in authoritative government prescribing information. Consequently, there are no official restrictions regarding co-administration with oral medications, alcohol, food, or herbal products. The regulatory context confirms that no systemic exposure-modifying substances or contraindicated combinations have been formally identified for this medicine.

Topical Co-administration Restriction

The only documented restriction is a procedural constraint concerning other ocular eye medications. This constraint is critical for preserving the efficacy of the co-administered drug.

Interacting Category Constraint Timing Rule Regulatory Basis
Other ocular eye medications (topical) Mandatory separation of administration At least 15 minutes between the two medications To prevent the physical displacement of the co-administered product from the eye surface

This rule ensures that the full effect of any co-administered eye treatment is retained. The overall regulatory interaction profile is defined by the absence of systemic interaction risks, with its focus limited solely to this mandatory topical administration timing rule.

Mechanism of Action

Viscofresh's active component, carmellose (carboxymethylcellulose), functions primarily through a biophysical mechanism on the anterior ocular surface.

Ocular Surface Interaction

The polyanionic polymer is directly administered to the corneal and conjunctival epithelia, forming a demulcent layer that is structurally analogous to the natural tear film's muco-aqueous phase. This action results in a non-specific binding interaction with the ocular surface.

Molecular and System-Level Modulation

At the cellular level, the glucopyranose subunits of carmellose are reported to function as a binder to the glucose receptor GLUT-1 on the corneal epithelial cells. This non-agonist interaction is hypothesized to stabilize the epithelial surface. The polymer's high viscosity and mucoadhesive properties increase the retention time of the solution on the eye. This extended coating mechanically reduces the shear forces occurring between the eyelid and the globe during the blink cycle. The systemic physiological consequence is the sustained passive hydration and physical protection of the exposed ocular surface tissues, modulating the external microenvironment of the cornea.

Dosage and Administration Information

How to Use Viscofresh

This information describes the standard administration of Viscofresh and should be followed as advised by a healthcare professional. Viscofresh is a tear substitute containing the lubricant Carmellose Sodium.


Administration Scope

Feature Guidelines
Route of Administration Ophthalmic use (Instillation into the affected eye(s)).
Dosing Rule One or two drops in the affected eye(s).
Frequency/Timing As often as necessary, or as directed by a specialist.
Preparation Requirements Solution must be used immediately after opening the single-dose container (vial) and any remaining solution must be discarded.
Age-Group Rules No specific age-group limitations are documented for use, but consultation with a doctor or pharmacist is advised.
Missed-Dose Rules Apply one drop to the affected eye(s) as soon as remembered, then return to the regular schedule. Do not use a double dose to compensate for a missed dose.

Procedural Structure

Instillation Steps:

  1. Wash hands thoroughly before use.
  2. Separate a single-dose vial from the strip and ensure the container is intact.
  3. Hold the single-dose vial vertically and twist the cap to open it.
  4. Gently pull down the lower eyelid to form a pocket or pouch.
  5. Turn the single-dose container upside down and squeeze it to apply one or two drops into the eye(s).
  6. Blink a couple of times to distribute the solution.
  7. Immediately discard the single-dose container after use, even if solution remains, to prevent contamination and potential injury.

Administration Constraints

Classification Rule
Administration Method Type Topical/Ophthalmic Instillation
Frequency Pattern As-needed (Pro re nata) or directed by specialist
Contact Lens Use Consult a doctor or pharmacist about use with contact lenses, as some versions may state that lenses do not need to be removed.

The established instruction set defines the ophthalmic route of administration with flexible dosing—one or two drops—to be used as-needed, according to the patient's symptoms or specialist's advice. The core of the protocol emphasizes hygienic, single-use application to maintain sterility, with a key procedural step being the immediate disposal of the vial after use. The use of Viscofresh during pregnancy and lactation is permitted based on clinical assessment.

Recent Clinical Evidence

Viscofresh: Recent Clinical Evidence

Research on Carmellose sodium, the active ingredient in Viscofresh, has been primarily evaluated in randomized controlled trials (RCTs) and summarized in systematic reviews and meta-analyses. These studies focus on adult patients diagnosed with Dry Eye Disease (DED), particularly those presenting with mild to moderate severity and fluctuating symptoms of irritation.

The research explored how symptoms change over time by monitoring patient-reported outcomes describing perceived discomfort (such as the Ocular Surface Disease Index score) and objective clinical signs, including Tear Film Break-Up Time (TBUT) and Ocular Surface Staining. The evidence base for subjective symptom findings reflects a substantial volume of data and is generally assigned a high level of consistency by evidence bodies. In contrast, findings for objective physical sign measurements are often classified at a moderate level by these bodies, reflecting more variability across studies.

Studies also explored specific formulations, with research examining preservative-free preparations compared to preserved drops. Outcomes linked to irritative states on the eye's surface were monitored in this research. Furthermore, the medicine has been evaluated in specific patient subgroups, including the elderly population with DED.

Research duration has focused mainly on short-term (around one month) and intermediate-term (up to three months) observation periods. Long-term effects are not fully established, and there is limited information for long-term outcomes beyond the typical follow-up window. The evidence base acknowledges limitations, including the inconsistent definition of DED across various studies and the fact that data for certain groups remain insufficient.

Key Studies & References

  1. Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye (NCT00987727)

Frequently Asked Questions (FAQ)

Common questions about Viscofresh (FAQ)

Q: Is Viscofresh the same type of product as other common treatments for the same condition?

According to official regulatory documents, Viscofresh is classified as an Eye Lubricant solution, often referred to as Artificial Tears. It is used for the symptomatic relief of dryness and irritation. This places it in a category of products known as demulcents, which work locally on the eye's surface.

Q: What is the difference between Viscofresh and other lubricant products?

A distinguishing feature of Viscofresh is that it is typically provided in single-dose containers and is formulated to be preservative-free. This approach is intended to maintain sterility and may reduce the potential for irritation compared to preserved products.

Q: Are there any reported long-term safety concerns with Viscofresh?

Official information indicates that use is permitted as often as necessary to relieve symptoms. However, the available research evidence supporting the product is primarily focused on short-term periods (up to three months). Data on outcomes beyond the typical follow-up period are limited, and long-term effects are not fully characterized in the current evidence base.

Q: Can Viscofresh be used while wearing contact lenses?

Official documentation advises users to consult a doctor or pharmacist regarding use with contact lenses. While some formulations of the active ingredient may not require lenses to be removed, it is generally advised to seek professional guidance specific to the product version for appropriate use.

Q: Is Viscofresh suitable for use by children or teenagers?

Safety and efficacy in the paediatric population are officially based on clinical experience, with adult usage patterns applied for administration. For children and teenagers, consultation with a healthcare professional is generally advised to determine appropriate use.

Q: Is Viscofresh known to cause any issues with driving or operating machinery?

Regulatory warnings note that the product may cause transient blurring of vision immediately after application. This temporary effect could potentially impair the ability to perform tasks that require clear vision, such as driving or operating machinery. Users should wait until their vision has completely cleared before engaging in these activities, as described in official warnings.

Q: What is the typical shelf life of an unopened container of Viscofresh?

The stability of the unopened product is confirmed until the expiration date printed on the container. This requires storing the product correctly, generally at or below 25 C and without freezing. Users should always check the package for the specific date before use.

Q: Why might a doctor suggest Viscofresh over another product?

A specialist may consider the product's official attributes, such as its enhanced viscosity and its formulation as a preservative-free solution in single-dose format. These documented properties are factors that may influence a healthcare professional's consideration when discussing an eye lubricant.

Q: Is the disposal instruction important for safety?

Yes, the administration guidelines explicitly mandate the immediate disposal of the single-dose container after use, even if solution remains. Official documentation states that this step is necessary to prevent contamination and the potential for eye injury associated with re-using the vial.

Q: How quickly should I expect to notice any effects from Viscofresh?

As an ophthalmic lubricant, the product is designed to provide symptomatic relief by moisturizing the eye's surface. The lubricating effects are typically experienced soon after application.

Q: Can Viscofresh be used for something other than its stated main purpose?

Official product labeling specifies that Viscofresh is intended for ophthalmic use only and is specifically indicated for the temporary relief of dry eye symptoms. The product's regulatory labeling focuses specifically on its indicated use; it does not describe or support use for other conditions.

Q: What should I do if I think Viscofresh is not working for me?

Official warnings advise discontinuing use and seeking guidance from a doctor if the condition worsens or persists for more than 72 hours. It is advised to consult a healthcare professional if you experience new or continued issues such as eye pain, vision changes, or increased redness or irritation.

Q: Are there different strengths or formulations of Viscofresh?

Yes, the active ingredient in Viscofresh, carmellose sodium, is commercially available in different strengths. These commonly include 0.5% (5 mg/mL) formulations, generally used for milder symptoms, and 1% (10 mg/mL) formulations, often used for moderate to severe symptoms.

Q: Is it necessary to shake the Viscofresh container before use?

Official administration instructions provide detailed steps for preparing and applying the drops, including washing hands and opening the vial correctly. These regulatory procedures do not include any instruction to shake the single-dose container before instilling the solution.

Q: What if I accidentally use more Viscofresh than intended?

When applied to the eye, the product is not expected to be hazardous even if more than the recommended amount is applied, due to its topical action. Official advice notes that if the solution is swallowed, immediate medical help or contacting a Poison Control Center is recommended.

Q: How long does the effect of a single application of Viscofresh typically last?

The product is formulated with high viscosity and mucoadhesive properties to increase its retention time on the eye’s surface. This mechanism is designed to provide sustained passive hydration and lubrication. Reapplication frequency is typically based on the user's specific symptomatic need, as directed in the official administration guidelines.

Q: What should I look for on the label to ensure I have the correct Viscofresh product?

To confirm you have the correct product, official guidelines recommend checking the label for the Active Ingredient (Carmellose Sodium) and the Strength (such as 0.5% or 1%). Users should also verify the Expiration Date and ensure that the solution inside the container is clear and that the package is intact.

Q: What are the common misunderstandings about the use of Viscofresh?

A critical regulatory instruction that is commonly overlooked is the requirement to immediately discard the single-dose container after use, even if solution remains. Official safety information emphasizes this point because re-using the container introduces a risk of contamination, which carries the potential for eye injury.

How should Viscofresh be stored and disposed of?

The official labeling for Viscofresh (Carmellose sodium) eye drops defines strict storage and disposal requirements to maintain product integrity and safety.


Storage Requirements

The medicine must be kept out of the sight and reach of children.

Condition Requirement
Temperature Store at or below 25 C; do not freeze.
Stability Use immediately after opening the single-dose container; do not re-use.
Integrity Do not use after the expiry date or if the solution changes color or becomes cloudy.

Disposal Instructions

Used single-dose containers may be placed in household waste.

Any unused or expired medicine must be returned to a pharmacist for disposal according to local guidelines, which ensures proper environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Viscofresh found in:

A-Z Index: